fluorouracil has been researched along with lutetium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, TW; Hicks, RJ; Hofman, MS; Thomson, BN | 1 |
Gillani, SJ; Naqvi, SA; Rasheed, R; Rasheed, S; Rizvi, FA; Sajid, M; Tariq, S | 1 |
2 other study(ies) available for fluorouracil and lutetium
Article | Year |
---|---|
The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable.
Topics: Aged; Antimetabolites, Antineoplastic; Duodenal Neoplasms; Fluorouracil; Humans; Lutetium; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptors, Peptide; Remission Induction; Research Design; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
(177) Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy.
Topics: Animals; Drug Stability; Fluorouracil; Half-Life; Isotope Labeling; Lutetium; Male; Quality Control; Rabbits; Radiochemistry; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2016 |